Geometry.Net - the online learning center
Home  - Health_Conditions - Mesothelioma
e99.com Bookstore
  
Images 
Newsgroups
Page 6     101-120 of 136    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Mesothelioma:     more books (100)
  1. Advances in Peritoneal Surface Oncology (Recent Results in Cancer Research)
  2. Advances in Peritoneal Surface Oncology (Recent Results in Cancer Research)
  3. Endobronchial Ultrasound: An Atlas and Practical Guide
  4. Frozen Section Library: Pleura by Philip T. Cagle, Timothy Craig Allen, 2010-03-19
  5. Premises liability.(California): An article from: Trial
  6. Daubert hearing is not a 'search for truth' Michigan court rules.: An article from: Trial by Susan Heylman, 2007-04-01
  7. Metabolic genotypes as modulators of asbestos-related pleural malignant [An article from: International Journal of Hygiene and Environmental Health] by M. Neri, E. Taioli, et all 2006-07-19
  8. The carcinogenicity of acrylamide [An article from: Mut.Res.-Genetic Toxicology and Environmental Mutagenesis] by J.M. Rice, 2005-02-07
  9. Duty owed to employee's daughter in asbestos case, Tenn. court rules.: An article from: Trial by Cecily Walters, 2008-12-01
  10. Employers' liability for asbestos diseases: House of Lords takes a turn in English law: recent House of Lords decision may indicate a return to the lower ... An article from: Defense Counsel Journal by Jessica Burt, 2002-07-01
  11. Nature and extent of the exposure to fibrous amphiboles in Biancavilla [An article from: Science of the Total Environment, The] by B.M. Bruni, A. Pacella, et all 2006-10-15
  12. Practical Thoracoscopy by Christian Boutin, Jean R. Viallat, et all 1991-03-15
  13. White Dust Black Death: The Tragedy of Asbestos Mining at Baryulgil by Peter Webster, 2006-07-06
  14. Cellular and Molecular Aspects of Fiber Carcinogenesis (Current Communications in Cell and Molecular Biology) by Curtis C. Harris, John F. Lechner, 1991-05-01

101. Mesothelioma - Online Lawyer Source
mesothelioma and Asbestos Information from Online Lawyer Source. Find all of yourlegal needs in one place from qualified attorneys.
http://www.onlinelawyersource.com/mesothelioma/
Mesothelioma
For more information and immediate legal advice please More Legal
Select Your State Alaska Alabama Arizona Arkansas California Colorado Connecticut Delaware D.C. Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
Mesothelioma
Contact a Mesothelioma Lawyer or State AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY
Mesothelioma is a rare form of cancer that attacks cells, called mesothelial cells that make up membrane lining in the chest and abdominal cavity. The tissue called mesothelium, which is formed by the mesothelial cells, help protects the organs by producing a lubricating fluid that allows the organs to move without irritating nerves. Almost always mesothelioma is caused by exposure to asbestos but some researchers believe the virus SV40 can also be a factor. While mesothelioma affects the lungs, it is not a lung cancer. Smokers are at risk for lung cancer, which in effect could lead to contracting other asbestos-related diseases. Lung cancer is more common and arises in the lungas inner tissues opposed to mesothelioma, which develops in the tissue that covers the lung.

102. Center For Mesothelioma And Asbestos-Related Diseases
The Thoracic Oncology Program at the University of Maryland Medical Center isone of the pioneering institutions nationally using a finely tuned
http://www.umm.edu/thoracic/mesothelioma.html
var MenuLinkedBy='AllWebMenus [2]', awmBN='530'; awmAltUrl='';
Thoracic Surgery Division
Request An Appointment Diagnostic and Treatment Emphysema... ... What's New for Physicians
//var DOCUMENTGROUP=''; //var DOCUMENTNAME=''; //var ACTION=''; Related Resources Within UMM Thoracic Oncology Program Outside UMM Mesothelioma Applied Research Foundation Mesothelioma Web Translate using Google
to Spanish German French Italian Portuguese
Thoracic Surgery Division
Center for Mesothelioma and Asbestos-Related Diseases
FOR MORE INFORMATION New mesothelioma protocol now open
Learn more about the current approach to mesothelioma treatment in this article written by Petr Hausner, M.D., Chief of Hematology/Oncology at the Baltimore Veterans Affairs Medical Center. The Thoracic Oncology Program at the University of Maryland Medical Center is one of the pioneering institutions nationally using a finely tuned multidisciplinary approach to the treatment of malignant mesothelioma and other asbestos-related diseases. With our multidisciplinary care program, patients have access to all of the team members in one visit. Treatment with medical, surgical and radiation oncologists is coordinated through one specialized nurse. Communication is maximized and patient stress and inconvenience is minimized. This "one-stop shopping" approach has been found to be the best way to tackle the complex care for this difficult disease. Mesothelioma Malignant mesothelioma, an uncommon form of cancer, is a disease in which cancer (malignant) cells are found in the sac lining the lung and chest cavity (the pleura), abdomen (the peritoneum) and the heart (the pericardium). A layer of specialized cells called mesothelial cells lines these cavities, forming tissue called mesothelium. Tumors of the meothelium can be benign (noncancerous) or malignant (cancerous). Most mesothelial tumors are cancerous; therefore, malignant mesothelioma is often simply called mesothelioma.

103. June Hancock Mesothelioma Research Fund
The June Hancock mesothelioma Research Fund (JHMRF) is merging with the BritishLung Foundation to work together to raise awareness of mesothelioma
http://www.leeds.ac.uk/meso/

Pioneer who linked dust to cancer dies

Scientist Professor Sir Richard Doll, who exposed the link between lung cancer and asbestos, has died at 92 June's charity merges with BLF
The June Hancock Mesothelioma Research Fund (JHMRF) is merging with the British Lung Foundation to work together to raise awareness of mesothelioma Just published
Revised and updated for 2005, Mavis Robinson's booklet gives information and guidance on mesothelioma for people with the disease and their carers. more

104. Selecting A Mesothelioma Attorney: Consumer Tips
Questions to ask when selecting a mesothelioma attorney.
http://www.scambusters.org/mesothelioma-attorney.html
Selecting a Mesothelioma Attorney: Consumer Tips
Questions to ask when selecting a mesothelioma attorney.
These pages provide consumer tips for how to deal with the financial aspects of selecting a mesothelioma attorney. They do not provide any information regarding the medical aspects of this serious disease. Since so much is at stake, selecting the right mesothelioma lawyer is very important. According the Wall Street Journal, lawyers say a typical mesothelioma award in a mesothelioma settlement is $1 million, and attorneys get 40% of this amount. If the case actually goes to trial, the average award was $6 million in 2001, which was triple the amount awarded just two years earlier. So, mesothelioma attorneys are very eager to find mesothelioma patients. And it's vital that patients select the mesothelioma attorneys that are best for them.
A Brief Background on Your Legal Rights Regarding Mesothelioma
Companies that manufacture products that contain asbestos have known for over 60 years that asbestos can cause serious diseases. Unfortunately, because many of these companies wanted to increase their profits, they kept this information quiet, thereby seriously endangering their workers.

105. Selecting A Mesothelioma Lawyer:
More questions to ask when selecting a mesothelioma attorney.
http://www.scambusters.org/mesothelioma-lawyer.html
Selecting a Mesothelioma Lawyer (continued): Consumer Tips
More questions to ask when selecting a mesothelioma lawyer.
(Note: Below you'll find questions #3 and #4 for finding a mesothelioma lawyer. If you haven't yet seen questions #1 and #2, or the brief background description of why these questions are important, we suggest you click here for this page of questions for selecing a mesothelioma attorney first.)
Question #3 to Ask When Selecting a Mesothelioma Lawyer:
A very important question to ask is how expenses and attorney fees will be handled for the case. The process is not fast preparation for the trial and then the trial itself will take many months (or even years). During this time, there will be thousands of dollars of initial costs associated with preparing for the trial, such as travel, hiring expert witnesses, depositions, etc. Ordinarily, the attorney who represents you advances these initial costs that are associated with the preparation and trial. Most attorney fees in these cases are based on contingency fee contracts. This means that the lawyers receive a percentage of the amount the victim recovers if the suit is successful. If the suit is not successful, then the attorneys earn no fee.

106. PET Imaging Of Pleural Mesothelioma
malignant mesothelioma involving both parietal and visceral pleura. Discussion.Malignant mesothelioma is an uncommon tumor of mesothelial cells in the
http://www.med.harvard.edu/JPNM/TF98_99/Mar16/WriteUp.html
Joint Program in Nuclear Medicine
PET Imaging of Pleural Mesothelioma
Hossein Jadvar, MD, PhD
Alan J. Fischman, MD, PhD
March 16, 1999
Presentation
A 67 year old male presented with cough and dyspnea. A chest radiograph (not showm) revealed moderately large left pleural effusion. A chest MRI (not shown) was also performed that showed contrast enhancement of the left pleura. FDG PET imaging and thoracoscopy were then performed.
Imaging Technique
Coronal FDG PET: Attenuation-corrected imaging 45 minutes after intravenous injection of 17 mCi FDG.
Imaging Findings
The series of coronal PET images , from anterior (top left) to posterior (bottom right), show asymmetric abnormal hypermetabolism surrounding the left hemithorax highly suspicious for malignancy.
Differential Diagnosis
The differential diagnosis for pleural disease is as follows:
  • Pleuritis Serofibrinous (TB, pneumonia, infarct, rheumatoid arthritis, uremia) Suppurative (empyema) Hemorrhagic (bleeding dyscrasia, neoplasm) Neoplasm Metastatic (lung cancer, breast cancer, ovarian cancer) Primary (benign and malignant mesothelioma)
  • Diagnosis
    The patient underwent thoracoscopy with pleural biopsy followed by left extrapleural pneumonectomy. Both the biopsy and the surgical specimen demonstrated extensive malignant mesothelioma involving both parietal and visceral pleura.

    107. Mesothelioma Treatment Options Page
    Articles regarding mesothelioma treatment options as well as mesothelioma patientprofiles, medical articles, ongoing protocols, risks and research.
    http://www.mesothel.com/pages/mesopage.htm
    Articles regarding mesothelioma treatment options as well as mesothelioma patient profiles, medical articles, ongoing protocols, risks and research.

    108. Mesothelioma Resource Center At JustMeso.com
    mesothelioma resource provides information about mesothelioma, asbestos, andrelated topics.
    http://www.justmeso.com/

    109. Health Report - 07/09/1998: Mesothelioma
    Research indicates that mesothelioma a form of cancer arising on the cells liningthe chest and abdominal cavities is becoming a more widespread problem
    http://www.abc.net.au/rn/talks/8.30/helthrpt/stories/s12150.htm
    Radio National
    with Norman Swan Mesothelioma
    Monday 7 September 1998
    Summary: Research indicates that Mesothelioma, a form of cancer arising on the cells lining the chest and abdominal cavities, is becoming a more wide-spread problem than initially considered. According to statistics from the Asbestos Diseases Research Centre at the University of Western Australia, more people are dying of a cancer called mesothelioma than of cervical cancer. In addition, the numbers are going up year by year and a growing proportion of the new diagnoses are in people with no known exposure to asbestos, the carcinogen people have assumed to be mesothelioma's cause.
    It's reason for concern and, says University of Western Australia researcher Dr Bill Musk, points to the problems which can arise if we ignore occupational diseases.
    Bill Musk is a respiratory physician who has studied occupational lung diseases for many years, especially among former workers of Wittenoom asbestos mine.
    Bill Musk: Mesothelioma is a form of malignancy that arises from the cells which line the chest wall or the abdominal cavity, or cover the lung and cover the bowel in the abdominal cavity.
    Norman Swan: Now why is the rate of notification going up, why are we getting increasing rise of cases when we seem to have whipped asbestos out of most of the situations we come across in life?

    110. Current Therapy For Mesothelioma
    The histopathologic diagnosis of mesothelioma can be difficult. The lack ofany curative single modality therapy for mesothelioma has led our group and
    http://www.moffitt.usf.edu/pubs/ccj/v4n4/article4.html
    Current Therapy for Mesothelioma
    David J. Sugarbaker, MD, Jose J. Norberto, MD, and Raphael Bueno, MD
    Malignant pleural mesotheliomas are locally aggressive, invasive, and almost universally fatal. Background: Diffuse malignant pleural mesotheliomas (DMPMs) are highly lethal tumors that are becoming more common. Standard management approaches have provided limited effectiveness.
    Methods: The literature on management has been revised, and the authors present their data on outcomes for 120 patients treated with an aggressive trimodality approach.
    Results: An aggressive trimodality approach including extrapleural pneumonectomy followed by chemoradiation produces low mortality and acceptable morbidity. The five-year survival rate in patients with epithelial histology and negative nodes approaches 40%.
    Conclusions: Nodal status and histologic subtype are major predictors for survival in patients with early DMPM. A uniformly accepted staging system would allow comparison of treatment approaches from various institutions. More effective management interventions are required.
    Introduction
    Mesotheliomas of the pleural cavity are relatively rare tumors. Generally, two types of pleural tumors can be referred to as mesotheliomas. The less common is the solitary (or localized) fibrous tumor of the pleura, previously known as "benign mesothelioma." This slow-growing, commonly benign, well-circumscribed tumor is pedunculated on a pleural-based pedicle and often is cured by resection. The tumor appears to originate from submesothelial rather than mesothelial or epithelial cells.

    111. Mesothelioma: BC Cancer Agency
    Chair Dr. S. Lam Respiratory Medicine VGH Members mesotheliomas are uncommontumours arising from the mesothelial surface (pleura, peritoneum,
    http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lung/Mesothelioma/
    Agency Links: Home Contact Us Legal Privacy ... Cancer Management Guidelines Mesothelioma Mesothelioma MesotheliomaStaging 1. Demographics 2. Predisposing Factors / Prevention 3. Screening / Early Detection ... Print this Page Chair Dr. S. Lam Respiratory Medicine VGH
    Members
    Mesotheliomas are uncommon tumours arising from the mesothelial surface (pleura, peritoneum, and rarely from sites such as the pericardium and tunica vaginalis testis). Diffuse mesotheliomas are invariably malignant. At the time of presentation, pleural mesothelioma usually is often confined to the thorax, however, disease typically contaminates the entire pleural cavity and pleural effusion is common. Later, there is extension to the chest wall, mediastinum and encasement of the lung with a thick rind of tumour. Regional lymph nodes may become involved. Extension through the diaphragm may cause peritoneal involvement and ascites. Hematogenous metastases are uncommon but may be seen particularly in patients surviving longer than average. Patients may present with chest pain, dyspnea and cough. The referring clinical problem may be pleural effusion of unknown etiology. Advancing disease causes respiratory insufficiency, chest wall pain, cardiovascular complications from invasion of the heart and general constitutional deterioration. (Revised May 2001)
    Print Wizard
    Print this Page
    The BC Cancer Agency is a part of the Provincial Health Services Authority
    If you notice a problem with this page, please report it via the

    112. About Mesothelioma - Asbestos Truth.org - Helping Mesothelioma Victims
    AsbestosTruth was founded by the Committee to Protect mesothelioma Victims (CPMV),an organization made up of asbestos victims and their families and
    http://www.asbestostruth.org/main/aboutmeso.html
    Home About the Bill About Mesothelioma News FAQ Personal Stories Take Action Now! About Mesothelioma What is it? Legislation Who gets it? Personal stories ... How you can help What is mesothelioma? Mesothelioma is
    a relatively rare
    type of cancer
    that usually kills
    within a year or
    two of diagnosis When they brought the asbestos fibers home each night in their clothes and hair, their families were also exposed. Thousands of Americans each year now develop mesothelioma, a malignant tumor that aggressively invades the linings of the lungs, abdomen, heart or testicles. By the time symptoms appear and cancer is diagnosed, the disease is often advanced. The average survival time is one year. What causes mesothelioma? Read about
    naturally
    occurring
    asbestos
    People exposed in the 1940s, 50s, 60s, and 70s are now being diagnosed with mesothelioma because of the long latency period of asbestos diseases. Take action! About the bill Victims of mesothelioma Factory workers covered with asbestos dust
    Waukegan, Illinois, 1987 Home About us Contact us Sitemap ...
    Breath Taken: The Landscape and Biography of Asbestos
    , is owned by Legal Notice . Website by Nash Interactive

    113. Mesothelioma Or Asbestos Cancer
    This article is about the horror and the history of mesothelioma or Asbestos Cancer.However, it is also about the Internet phenomenon that has grown up
    http://www.americanhomeinspectordirectory.com/mesothelioma.htm
    Web www.americanhomeinspectordirectory.com
    Mesothelioma or Asbestos Cancer
    This article is about the horror and the history of Mesothelioma, or Asbestos Cancer. However, it is also about the phenomenon that has grown up around this dreadful asbestos environmental hazard.
    Mesothelioma: What is it?
    Mesothelioma is a malignant cancerous disease of the cells lining the patient's body cavities such as chest, abdominal region or the area surrounding the heart. It is thought to be associated with exposure to asbestos, and this asbestos association has been documented in 70-80% of all mesothelioma cases. Asbestos cancer or mesothelioma is very difficult to assess and diagnose consistently. The time between exposure and the onset of the disease, and the rate of progression of malignant mesothelioma, make diagnosis very difficult. It is believed that even insignificant exposure to asbestos in environments such as asbestos mills, mines, shipping yards, some older Navy ships or even patient's homes can result in mesothelioma. In many cases mesothelioma does not occur for decades after initial exposure to this cancer-causing asbestos. 2000-3000 cases of mesothelioma per year are currently being diagnosed. Family members of workers exposed to asbestos can also contract this disease through exposure to the worker's clothing. Like many other cancers, smoking greatly increases the risk of contracting mesothelioma. Some of the earliest symptoms of mesothelioma are commonly over looked due there similarity to symptoms of less serious diseases. Some patients do not show any signs of sickness in the early stages of development of the disease. The most common symptoms of mesothelioma include dyspnoea, pleuritic pain, lasting cough, fatigue, and weight loss. These symptoms may not be attributed to mesothelioma unless the patient is examined by a competent and knowledgeable health care provider who orders the appropriate tests. Test for mesothelioma, or asbestos cancer, may include CT scans, x-rays scans, or MRI. Surgery can be one of the treatment options; however, the recurrence rate of cancerous cells is high. It is very important that the disease is diagnosed and treated as early as possible.

    114. Mesothelioma UK
    mesothelioma UK provides impartial upto-date information for patients diagnosed mesothelioma UK have been given permission to provide a link to the
    http://www.mesothelioma.uk.com/
    About Us Contact Us Helpline No NHS Cancer Care ... Acknowledgements A A A Accessibility
    Options
    Printer Friendly Version Mesothelioma UK Mesothelioma UK provides impartial up-to-date information for patients diagnosed with Mesothelioma and their carers. The Centre supports the development of specialist nursing practice and research which promotes the highest possible standards of care. A Nurse Consultant has been appointed to lead the development of Mesothelioma UK. There is a free phone helpline available which provides access to timely, accurate and relevant advice for patients, carers and health care professionals. Callers will be able to access local information and support and be signposted to relevant websites. Mavis Robinson's Booklet, revised and updated for 2005, gives information and guidance on Mesothelioma for people with the disease and their carers. Mesothelioma UK have been given permission to provide a link to the booklet on the June Hancock Mesothelioma Research Fund website.
    Please follow this link www.leeds.ac.uk/meso/MesotheliomaBooklet.pdf

    115. Mesothelioma - Recognizing The Symptoms
    How to recognize the symptoms of mesothelioma. mesothelioma is so difficultto diagnose early because the symptoms are often mistaken for those of other
    http://www.rlrouse.com/mesothelioma.html
    Add URL Site map Home Add URL ... Site map
    Mesothelioma - Recognizing The Symptoms
    Recognizing the symptoms of Mesothelioma
    Mesothelioma is a very serious malignant tumor that affects the torso of the human body. There is a very strong link between mesothelioma and exposure to asbestos particles (by breathing or swallowing). There are three common forms of mesothelioma:
  • Pleural Mesothelioma is the most common form of Mesothelioma. It starts in the chest cavity (after breathing the particles) before spreading to other areas.
  • Peritoneal Mesothelioma starts in the abdomen (after swallowing the particles) and accounts for about 10-20% of Mesothelioma patients.
  • Pericardial Mesothelioma is the rarest form of Mesothelioma. It starts in the cavity that surrounds the heart.
  • Mesothelioma is so difficult to diagnose early because the symptoms are often mistaken for those of other, less serious ailments. To make matters worse, it often takes many years for the symptoms to show up after the asbestos exposure takes place.
    Here is a list of the most common Mesothelioma symptoms:
    • Difficulty breathing (shortness of breath)
    • A cough that won't go away
    • A change in your normal coughing pattern
    • Frequent hoarseness or raspy voice
    • Significant weight loss that cannot be explained
    • Difficulty swallowing
    • Pain in the chest or abdomen
    • Coughing up blood
    If you experience one or more of these symptoms of Mesothelioma for more than a short period of time, you should consult your physician right away. Mesothelioma, by its very nature, is very difficult to diagnose early (many people simply ignore the symptoms at first).

    116. ALIMTA.com — Mesothelioma And Safety Information From Eli Lilly
    Official pharmaceutical site with information for patients and health professionals.
    http://www.alimta.com/
    window.open('/common_pages/home_popup.html','myWin','width=320,height=240'); Cancer Resources Site Map Ask Lilly Glossary ... Privacy Statement

    117. National Cancer Institute - Malignant Mesothelioma Home Page
    NCI s gateway for information about malignant mesothelioma.
    http://www.nci.nih.gov/cancertopics/types/malignantmesothelioma/
    var bSearchBoxBool=false; Quick Links Director's Corner
    Dictionary of Cancer Terms

    NCI Drug Dictionary

    Funding Opportunities
    ...
    NIH Calendar of Events

    NCI Highlights NCI Offers Support for Those in Need After Katrina
    NCI Announces Plan to Fight Lung Cancer

    National Prostate Cancer Awareness Month

    National Ovarian Cancer Awareness
    ...
    Past Highlights

    Malignant Mesothelioma Related Pages What You Need To Know About Cancer - An Overview An overview of cancer detection, symptoms, diagnosis, and treatment. NIH Publication No. Mesothelioma: Questions and Answers A fact sheet that describes the risk factors, symptoms, diagnosis, and treatment of mesothelioma. Full description of the NCI PDQ database. General Cancer Resources Coping with Cancer Managing side effects and complications caused by cancer and its treatment. Support and Resources Information about cancer support organizations, finances, insurance, home care, and hospice care. Learning About Clinical Trials Types of trials, how they work, risks and benefits of taking part. Finding Clinical Trials Ways to look for specific cancer clinical trials.

    118. Malignant Mesothelioma Information Center
    More than 100 pages of indepth information on types of malignant mesothelioma,diagnosis, treatment, clinical trials, litigation and asbestos exposure.
    http://www.allaboutmalignantmesothelioma.com/
    All About Malignant Mesothelioma
    On this page: Introduction Malignant Mesothelioma Etiology See also: updated 8 September 2005 Malignant mesothelioma is a rare form of cancer that affects the mesothelial cells of the serous membranes in the body. The most common form of mesothelioma, affecting the lining of the lung, is pleural mesothelioma. Two to three thousand new cases of malignant mesothelioma are diagnosed each year. The mission of All About Malignant Mesothelioma is to provide a one-stop resource for comprehensive, up-to-date mesothelioma information. We cover the full scope of malignant mesothelioma issues including background, history, risk factors, diagnosis, treatment and legal rights. Please contact us if you have feedback about this website, and recommend it to someone who may benefit from mesothelioma information.
    Introduction to Malignant Mesothelioma
    Malignant mesothelioma affects the lining or membranes of certain large cavities in the body. These cavities, called the serous cavities, house certain major organs in the body including the heart, lungs, abdomen and others. The membranes that surround these cavities are called the serous membranes. They serve to protect these major organs from the friction and abrasion that occur as the organs move against each other during typical daily functioning, such as breathing and heart beating. The serous membranes derive from specialized cells called mesothelial cells. These cells form to create the mesothelium, which is the major tissue layer of the serous membranes. Cancer that occurs in the mesothelium tissue is called mesothelioma.

    119. Mesothelioma Clinical Trials.
    Histologically verified diagnosis of malignant mesothelioma Histologicallyconfirmed malignant peritoneal mesothelioma 02 prior chemotherapy regimens
    http://cpmcnet.columbia.edu/dept/medicine/mesothelioma/clinmeso.html
    Mesothelioma
    Clinical Trials (Updated 28-Feb-03)
    Onconase plus Doxorubicin vs. Doxorubicin Title: Multicenter randomized comparative phase III trial of onconase plus doxorubicin vs. doxorubicin in patients with malignant mesothelioma (part II) Eligibility Requirements:
    Histologically verified diagnosis of malignant mesothelioma
    Pathology slides must be available for independent review
    Patients aged 21 years or older
    Chemotherapy naive or 1 prior chemo (excluding doxorubicin) Treatment Plan:
    Randomized to either Onconase plus doxorubicin or doxorubicin alone
    Group I: Onconase will be given as a bolus intravenous infusion over 30 minutes weekly followed by a bolus intravenous infusion of doxorubicin every 3 weeks
    Group II: Doxorubicin will be given as a bolus intravenous infusion every 3 weeks Trimodal Therapy Title: Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation in peritoneal mesothelioma Eligibility Requirements:
    Histologically confirmed malignant peritoneal mesothelioma 0-2 prior chemotherapy regimens allowed At least 6 weeks since chemotherapy No prior radiation to abdomen or lower chest Treatment Plan: Exploratory laparotomy will be done to try to remove all lesions > 1cm. Three to 4 weeks later, doxorubicin, alternating with cisplatin and gemcitabine, will be administered intraperitoneally for approximately 12 weeks. Gamma-interferon will be given weekly for the last 4 weeks of chemotherapy. After a second- look surgery, patients will commence radiotherapy, which will last 5-7 weeks

    120. ACS :: Mesothelioma Drug Approved
    The US Food and Drug Administration has approved the drug Alimta for treatmentof malignant mesothelioma, a cancer of the lining of the chest and abdomen.
    http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Mesothelioma_Drug_Approved.as
    Home Community Get Involved Donate ... Site Index powered by GetRandomImage("headerImage", "jpg", 121, 77, 30); My Planner Register Sign In
    The US Food and Drug Administration has approved the drug Alimta for treatment of malignant mesothelioma, a cancer of the lining of the chest and abdomen. ACS News Center Medical Updates News You Can Use Stories of Hope ... I Want to Help You can help in the fight against cancer. Donate and volunteer. It's easy and fun! Learn more Mesothelioma Drug Approved Alimta First Effective Treatment for Rare Cancer Article date: The US Food and Drug Administration (FDA) has approved a new drug for treatment of malignant mesothelioma , a cancer of the lining of the chest and abdomen. Pemetrexed disodium, sold under the name Alimta, is the first drug shown to help patients with this rare form of cancer. "Up to now, there has been no effective treatment for mesothelioma," said FDA Commissioner Mark McClellan in announcing the approval. "Alimta offers new promise in treating this fatal cancer." Malignant mesothelioma is a cancer associated with heavy exposure to asbestos that affects 2,000 to 3,000 Americans every year. Because

    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

    Page 6     101-120 of 136    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | Next 20

    free hit counter